切换至 "中华医学电子期刊资源库"
高级检索
中华脑科疾病与康复杂志(电子版)

中华脑科疾病与康复杂志(电子版) ›› 2021, Vol. 11 ›› Issue (06) : 358 -361. doi: 10.3877/cma.j.issn.2095-123X.2021.06.008

临床研究

老年轻型缺血性卒中后认知障碍与血清神经丝蛋白轻链的相关性研究
王未飞1, 李广峰2, 庄献博1, 闫冠华1,†()   
  1. 1. 252000　山东聊城，聊城市人民医院神经内科
    2. 252000　山东聊城，聊城市人民医院神经外科
  • 收稿日期:2021-10-21 出版日期:2021-12-15
  • 通信作者: 闫冠华

Correlation between cognitive impairment and serum neurofilament-light level in eldly patients with minor ischemic stroke

Weifei Wang1, Guangfeng Li2, Xianbo Zhuang1, Guanhua Yan1,†()   

  1. 1. Department of Neurology, Liaocheng People’s Hospital, Liaocheng 252000, China
    2. Department of Neurosurgery, Liaocheng People’s Hospital, Liaocheng 252000, China
  • Received:2021-10-21 Published:2021-12-15
  • Corresponding author: Guanhua Yan
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王未飞, 李广峰, 庄献博, 闫冠华. 老年轻型缺血性卒中后认知障碍与血清神经丝蛋白轻链的相关性研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2021, 11(06): 358-361.

Weifei Wang, Guangfeng Li, Xianbo Zhuang, Guanhua Yan. Correlation between cognitive impairment and serum neurofilament-light level in eldly patients with minor ischemic stroke[J/OL]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2021, 11(06): 358-361.

目的

探讨血清神经丝蛋白轻链（NfL）与老年轻型缺血性卒（MIS）中6个月后认知障碍的相关性。

方法

前瞻性纳入自2019年3月至2020年6月于聊城市人民医院神经科住院治疗的老年MIS患者，采用单分子免疫阵列分析法测定血清NfL水平；发病后6个月时采用蒙特利尔认知功能量表进行测评，分为认知障碍组和认知正常组，比较2组患者血清NfL水平的差异，通过统计分析血清NfL水平与认知障碍的关系。

结果

最终纳入113例患者，6个月随访时47例（41.6%）出现认知功能障碍（认知障碍组），余66例（58.4%）为认知正常组。认知障碍组患者血清NfL水平、年龄、Fazekas评分、高血压患者占比均高于认知正常组，差异具有统计学意义（P<0.05）。多因素Logistic回归分析结果显示高血压、Fazeka评分、血清NfL水平是老年MIS后认知障碍的危险因素（P<0.05）。

结论

对于老年MIS患者，血清NfL水平升高是发生认知障碍的独立预测指标。

关键词: 轻型缺血性卒中, 认知障碍, 血清神经丝蛋白轻链
Objective

To investigate the relationship between serum neurofilament-light (NfL) level and post-stroke cognitive impairment 6 months after minor ischemic stroke (MIS) in eldly patients.

Methods

From March 2019 to June 2020, eldly patients with mild ischemic stroke who were admitted to the Neurology Department of Liaocheng People’s Hospital were prospectively enrolled. Serum NfL levels were measured by single molecule array. On the 6 months, all patients were divided into cognitive impairment group and cognitive normal group according to the score of Montreal cognitive assessment. The difference of serum NfL levels between the two groups was tested, and the relationship between the serum NfL level and cognitive impairment was statistically analyzed.

Results

Finally 113 elderly patients were included statistical analysis. At 6-month follow-up, 47 cases (41.6%) were diagnosed as post-stroke cognitive impairment (the cognitive impairment group), and the remaining 66 cases (58.4%) were the cognitive normal group. Compared with the cognitive normal group, the serum NfL level age, Fazekas score and the percentage of hypertension in the cognitive impairment group were all significantly higher (P<0.05). Multivariate logistic regression analysis showed that hypertension, Fazekas scale and serum NfL level were risk factors for cognitive impairment after MIS in the elderly (P<0.05).

Conclusion

For elderly patients with MIS, elevated serum neurofilament light levels are independent risk factors for cognitive impairment.

Key words: Minor ischemic stroke, Cognitive impairment, Serum neurofilament-light
表1 认知障碍组与认知正常碍组患者基线资料及血清NfL水平比较
组别 例数 年龄（岁，Mean±SD） 男性[例（%）] 吸烟[例（%）] 饮酒[例（%）] 高血压[例（%）] 糖尿病[例（%）] 高脂血症[例（%）] Fazeka评分[分，M（QR）] NIHSS评分[分，M（QR）] NfL（pg/mL，Mean±SD）
认知正常组 66 68.9±7.2 35（53.0） 17（25.8） 20（30.3） 34（51.5） 26（39.4） 28（42.4） 2.0（2.0） 1.5（3.0） 55.32±12.41
认知障碍组 47 74.2±10.3 28（59.6） 14（29.8） 12（25.5） 36（76.6） 21（44.7） 19（40.4） 3.0（3.0） 2.0（3.0） 73.84±19.25
t/χ2/Z值   3.061 0.028 0.405 1.014 5.806 0.003 0.011 3.488 0.367 3.460
P值   0.003 0.896 0.536 0.375 0.018 0.952 0.924 <0.001 0.592 0.001
表2 认知障碍组与认知正常组患者各亚认知域评分比较（Mean±SD）
组别 例数 视空间与执行能力 命名 注意与计算力 语言 抽象能力 延迟记忆 定向力
认知正常组 66 4.56±0.43 2.89±0.32 5.52±0.48 2.74±0.22 1.89±0.14 4.37±0.46 5.81±0.33
认知障碍组 47 3.67±0.35 2.87±0.31 5.06±0.36 2.61±0.18 1.42±0.25 3.18±0.61 5.77±0.30
t值   2.714 0.612 2.139 0.750 2.187 3.035 0.402
P值   0.007 0.536 0.042 0.446 0.035 0.004 0.731
表3 老年轻型缺血性卒中后认知障碍的多因素Logistic回归分析
自变量 回归系数 标准误 Wald值 OR值 95%CI P值
高血压 1.024 1.275 3.151 2.516 1.195~8.263 0.038
Fazeka评分 0.869 1.161 7.041 1.824 1.337~3.290 0.004
血清NfL 1.328 0.947 4.267 1.216 1.016~2.382 0.016
[1]
Kapoor A, Lanctot KL, Bayley M, et al. Screening for post-stroke depression and cognitive impairment at baseline predicts long-term patient-centered outcomes after stroke[J]. J Geriatr Psychiatry Neurol, 2019, 32(1): 40-48.
[2]
Zetterberg H, Skillbäck T, Mattsson N, et al. Association of cerebrospinal fluid neurofilament light concentration with alzheimer disease progression[J]. JAMA Neurol, 2016, 73(1): 60-67.
[3]
Olsson B, Portelius E, Cullen NC, et al. Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders[J]. JAMA Neurol, 2019, 76(3): 318-325.
[4]
中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682.
[5]
Marques TM, van Rumund A, Oeckl P, et al. Serum NFL discriminates parkinson disease from atypical parkinsonisms[J]. Neurology, 2019, 92(13): e1479-e1486.
[6]
Li J, You SJ, Xu YN, et al. Cognitive impairment and sleep disturbances after minor ischemic stroke[J]. Sleep Breath, 2019, 23(2): 455-462.
[7]
Malojcic B, Giannakopoulos P, Sorond FA, et al. Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer’s disease[J]. BMC Med, 2017, 15(1): 27.
[8]
邹永明，田志岩，张惠红, 等. 不同类型痴呆患者阿尔茨海默病相关神经丝蛋白水平和嗅觉功能差异的比较[J]. 中华老年医学杂志, 2018, 37(7): 738-742.
[9]
Pereira JB, Westman E, Hansson O, et al. Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer’s disease[J]. Neurobiol Aging, 2017, 58: 14-29.
[10]
Gaetani L, Blennow K, Calabresi P, et al. Neurofilament light chain as a biomarker in neurological disorders[J]. J Neurol Neurosurg Psychiatry, 2019, 90(8): 870-881.
[11]
彭丽君，钱海蓉，毛琳玲, 等. 神经丝蛋白轻链在视神经脊髓炎谱系疾病诊断和预后中的意义[J]. 中华神经科杂志, 2017, 50(6): 430-434.
[12]
Mattsson N, Cullen NC, Andreasson U, et al. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease[J]. JAMA Neurol, 2019, 76(7): 791-799.
[13]
van der Ende EL, Meeter LH, Poos JM, et al. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study[J]. Lancet Neurol, 2019, 18(12): 1103-1111.
[14]
Novakova L, Zetterberg H, Sundström P, et al. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein[J]. Neurology, 2017, 89(22): 2230-2237.
[15]
Byrne LM, Rodrigues FB, Blennow K, et al. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington’s disease: a retrospective cohort analysis[J]. Lancet Neurol, 2017, 16(8): 601-609.
[16]
Weston PSJ, Poole T, Ryan NS, et al. Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration[J]. Neurology, 2017, 89(21): 2167-2175.
[17]
Gattringer T, Pinter D, Enzinger C, et al. Serum neurofilament light is sensitive to active cerebral small vessel disease[J]. Neurology, 2017, 89(20): 2108-2114.
[18]
Levine DA, Wadley VG, Langa KM, et al. Risk factors for poststroke cognitive decline: the REGARDS study (reasons for geographic and racial differences in stroke)[J]. Stroke, 2018, 49(4): 987-994.
[19]
Liang Y, Chen YK, Liu YL, et al. Cerebral small vessel disease burden is associated with accelerated poststroke cognitive decline: a 1-year follow-up study[J]. J Geriatr Psychiatry Neurol, 2019, 32(6): 336-343.
[1] 王诗远, 张爱华. 慢性肾脏病相关认知障碍的发生机制研究进展[J/OL]. 中华肾病研究电子杂志, 2023, 12(03): 163-167.
[2] 吉莉, 苏云楠, 王斌, 沈滔, 刘团结, 毛蕾, 徐玉萍, 张婷, 王博. 急性缺血性脑卒中患者脑白质微结构改变对长期认知功能损伤的预测价值研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 193-200.
[3] 李瑞雨, 王新亮, 徐丛丛, 刘严泽, 张雪竹. 国内外血管性认知障碍临床试验注册现状分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 14-20.
[4] 马良飞, 尹翎, 方婷, 曾西西, 佟佳璇, 马献昆. 重复经颅磁刺激联合虚拟现实技术对脑卒中后认知障碍的影响[J/OL]. 中华脑科疾病与康复杂志(电子版), 2023, 13(06): 346-351.
[5] 常文轩, 王婷, 刘伟, 蓝天琦, 彭静, 汪诗瑶, 张晓鹏, 冯晨, 宫雪梅, 朱敏. 脑小血管病所致执行障碍的研究进展[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(03): 179-182.
[6] 赵金义, 孙正莹, 李洪义, 胡明成, 王晓申, 史晓航, 王煜宁, 孙维洋, 邢健. 基于结构磁共振成像评估皮质下缺血性脑血管病伴认知障碍患者灰质萎缩的影像学研究[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(01): 10-14.
[7] 高倩, 李晓芳, 杨亚昭, 张静, 崔蕾, 杨立青, 夏艳敏. 甲状腺激素及Apelin在CSVD致认知障碍的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 201-206.
[8] 欧春影, 李晓宾, 郭靖, 许可, 王梦, 安晓雷. hs-CRP、Lp-PLA2和S100β与缺血性脑小血管病患者认知障碍的相关性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(03): 265-269.
[9] 赵晓晓, 邱嘉婷, 张懿姝, 张蓉, 张棚, 刘晓蕾. 丁苯酞在各类型认知障碍治疗中的应用研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(01): 19-26.
[10] 叶一, 曾勇. 血脂与轻度认知障碍相关性的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(01): 14-18.
[11] 孙畅, 赵世刚, 白文婷. 脑卒中后认知障碍与内分泌激素变化的关系[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(05): 471-476.
[12] 王道合, 施媛媛. 8-iso-PGF2α及P选择素在评估脑小血管病患者认知功能中的价值[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(04): 364-368.
[13] 夏禹, 刘寒, 朱瑞. 阿尔茨海默病及相关认知障碍疾病与早老素2基因相关性的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(03): 290-293.
[14] 张宇, 蔡玉洁, 林日清, 邱钦杰, 崔理立, 郑东, 周海红. 张力蛋白1对放射性脑损伤小鼠认知功能的影响[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(03): 244-253.
[15] 楚长彪. 卒中后认知障碍的管理[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(02): 0-0.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号